SynthesisThe Journal of clinical endocrinology and metabolism2023

Paricalcitol and Extended-Release Calcifediol for Treatment of Secondary Hyperparathyroidism in Non-Dialysis Chronic Kidney Disease: Results From a Network Meta-Analysis.

Matteo Franchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.